Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Type 1 Sodium Calcium Exchanger Forms a Complex with Carbonic Anhydrase IX and Via Reverse Mode Activity Contributes to pH Control in Hypoxic Tumors.

Liskova V, Hudecova S, Lencesova L, Iuliano F, Sirova M, Ondrias K, Pastorekova S, Krizanova O.

Cancers (Basel). 2019 Aug 9;11(8). pii: E1139. doi: 10.3390/cancers11081139.

2.

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.

Fava C, Rege-Cambrin G, Dogliotti I, Cerrano M, Berchialla P, Dragani M, Rosti G, Castagnetti F, Gugliotta G, Martino B, Gambacorti-Passerini C, Abruzzese E, Elena C, Pregno P, Gozzini A, Capodanno I, Bergamaschi M, Crugnola M, Bocchia M, Galimberti S, Rapezzi D, Iurlo A, Cattaneo D, Latagliata R, Breccia M, Cedrone M, Santoro M, Annunziata M, Levato L, Stagno F, Cavazzini F, Sgherza N, Giai V, Luciano L, Russo S, Musto P, Caocci G, Sorà F, Iuliano F, Lunghi F, Specchia G, Pane F, Ferrero D, Baccarani M, Saglio G.

Haematologica. 2019 Aug;104(8):1589-1596. doi: 10.3324/haematol.2018.205054. Epub 2019 Feb 28.

3.

Pyruvate dehydrogenase kinase 1 and carbonic anhydrase IX targeting in hypoxic tumors.

Kery M, Oravcova N, Radenkovic S, Iuliano F, Tomaskova J, Golias T.

Neoplasma. 2018 Dec 10;66(1):63-72. doi: 10.4149/neo_2018_180531N357.

PMID:
30509100
4.

Hypoxia induces cancer-associated cAMP/PKA signalling through HIF-mediated transcriptional control of adenylyl cyclases VI and VII.

Simko V, Iuliano F, Sevcikova A, Labudova M, Barathova M, Radvak P, Pastorekova S, Pastorek J, Csaderova L.

Sci Rep. 2017 Aug 31;7(1):10121. doi: 10.1038/s41598-017-09549-8.

5.

Synthesis and Biological Activities of Ethyl 2-(2-pyridylacetate) Derivatives Containing Thiourea, 1,2,4-triazole, Thiadiazole and Oxadiazole Moieties.

Szulczyk D, Tomaszewski P, Jóźwiak M, Kozioł AE, Lis T, Collu D, Iuliano F, Struga M.

Molecules. 2017 Mar 6;22(3). pii: E409. doi: 10.3390/molecules22030409.

6.

THIOUREA DERIVATIVES OF 4-AZATRICYCLO[5.2.2.0(2.6)]UNDEC-8-ENE-3,5 DIONE - SYNTHESIS AND BIOLOGICAL ACTIVITY.

Bielenica A, Stefańska J, Kozioł AE, Iuliano F, Collu D, Sanna G, Jóźwiak M, Struga M.

Acta Pol Pharm. 2016 May-Jun;73(3):693-703.

PMID:
27476288
7.

Antimicrobial and Anti-biofilm Activity of Thiourea Derivatives Bearing 3-amino-1H-1,2,4-triazole Scaffold.

Stefanska J, Stepien K, Bielenica A, Szulczyk D, Miroslaw B, Koziol AE, Sanna G, Iuliano F, Madeddu S, Jozwiak M, Struga M.

Med Chem. 2016;12(5):478-88.

PMID:
26648331
8.

Carnosine inhibits carbonic anhydrase IX-mediated extracellular acidosis and suppresses growth of HeLa tumor xenografts.

Ditte Z, Ditte P, Labudova M, Simko V, Iuliano F, Zatovicova M, Csaderova L, Pastorekova S, Pastorek J.

BMC Cancer. 2014 May 22;14:358. doi: 10.1186/1471-2407-14-358.

9.

Quinoline tricyclic derivatives. Design, synthesis and evaluation of the antiviral activity of three new classes of RNA-dependent RNA polymerase inhibitors.

Carta A, Briguglio I, Piras S, Corona P, Boatto G, Nieddu M, Giunchedi P, Marongiu ME, Giliberti G, Iuliano F, Blois S, Ibba C, Busonera B, La Colla P.

Bioorg Med Chem. 2011 Dec 1;19(23):7070-84. doi: 10.1016/j.bmc.2011.10.009. Epub 2011 Oct 13.

PMID:
22047799
10.

High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study.

Balduini CL, Gugliotta L, Luppi M, Laurenti L, Klersy C, Pieresca C, Quintini G, Iuliano F, Re R, Spedini P, Vianelli N, Zaccaria A, Pogliani EM, Musso R, Bobbio Pallavicini E, Quarta G, Galieni P, Fragasso A, Casella G, Noris P, Ascari E; Italian TTP Study Group.

Ann Hematol. 2010 Jun;89(6):591-6. doi: 10.1007/s00277-009-0877-5. Epub 2009 Dec 23.

PMID:
20033409
11.

Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party.

Castagnetti F, Palandri F, Amabile M, Testoni N, Luatti S, Soverini S, Iacobucci I, Breccia M, Rege Cambrin G, Stagno F, Specchia G, Galieni P, Iuliano F, Pane F, Saglio G, Alimena G, Martinelli G, Baccarani M, Rosti G; GIMEMA CML Working Party.

Blood. 2009 Apr 9;113(15):3428-34. doi: 10.1182/blood-2007-08-103499. Epub 2009 Feb 11.

12.

153Sm: its use in multiple myeloma and report of a clinical experience.

Abruzzese E, Iuliano F, Trawinska MM, Di Maio M.

Expert Opin Investig Drugs. 2008 Sep;17(9):1379-87. doi: 10.1517/13543784.17.9.1379 .

PMID:
18694370
13.

Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia.

Molica S, Digiesi G, Mauro F, Mirabelli R, Cutrona G, Vitelli G, Morabito F, Iuliano F, Foà R, Ferrarini M.

Leuk Res. 2009 Jan;33(1):162-5. doi: 10.1016/j.leukres.2008.05.004. Epub 2008 Jun 16.

PMID:
18556064
14.

Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome.

Palandri F, Iacobucci I, Castagnetti F, Testoni N, Poerio A, Amabile M, Breccia M, Intermesoli T, Iuliano F, Rege-Cambrin G, Tiribelli M, Miglino M, Pane F, Saglio G, Martinelli G, Rosti G, Baccarani M; GIMEMA Working Party on CML.

Haematologica. 2008 May;93(5):770-4. doi: 10.3324/haematol.12265. Epub 2008 Mar 26.

15.

PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation.

Leone V, di Palma A, Ricchi P, Acquaviva F, Giannouli M, Di Prisco AM, Iuliano F, Acquaviva AM.

Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G673-81. Epub 2007 Jul 19.

16.

Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party.

Rosti G, Iacobucci I, Bassi S, Castagnetti F, Amabile M, Cilloni D, Poerio A, Soverini S, Palandri F, Rege Cambrin G, Iuliano F, Alimena G, Latagliata R, Testoni N, Pane F, Saglio G, Baccarani M, Martinelli G.

Haematologica. 2007 Jan;92(1):101-5.

17.

Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.

Iacobucci I, Rosti G, Amabile M, Poerio A, Soverini S, Cilloni D, Testoni N, Abruzzese E, Montefusco E, Ottaviani E, Iuliano F, Russo D, Gobbi M, Alimena G, Martino B, Terragna C, Pane F, Saglio G, Baccarani M, Martinelli G.

J Clin Oncol. 2006 Jan 20;24(3):454-9.

PMID:
16421422
18.

Up-regulation of prostaglandin biosynthesis by leukotriene C4 in elicited mice peritoneal macrophages activated with lipopolysaccharide/interferon-{gamma}.

Rossi A, Acquaviva AM, Iuliano F, Di Paola R, Cuzzocrea S, Sautebin L.

J Leukoc Biol. 2005 Oct;78(4):985-91. Epub 2005 Jul 26.

PMID:
16046553
19.

Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial.

Bocchia M, Gentili S, Abruzzese E, Fanelli A, Iuliano F, Tabilio A, Amabile M, Forconi F, Gozzetti A, Raspadori D, Amadori S, Lauria F.

Lancet. 2005 Feb 19-25;365(9460):657-62.

PMID:
15721470
20.

Cytosolic carbonic anhydrase activity in chronic myeloid disorders with different clinical phenotype.

Bonapace G, Iuliano F, Molica S, Peta A, Strisciuglio P.

Biochim Biophys Acta. 2004 Aug 4;1689(3):179-81.

21.

Serum levels of vascular endothelial growth factor in chronic leukemias. A comparative study with emphasis on myeloproliferative disorders.

Molica S, Santoro R, Iuliano F, Di Raimondo F, Fichera E, Giustolisi R.

Haematologica. 2001 Jul;86(7):771. No abstract available.

22.

Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.

Stelitano C, Morabito F, Kropp MG, Callea V, Iuliano F, Oriana V, Levato D, Nobile F, Molica S, Brugiatelli M.

Haematologica. 1999 Apr;84(4):317-23.

23.

Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.

Molica S, Mannella A, Dattilo A, Levato D, Iuliano F, Peta A, Consarino C, Magro S.

Haematologica. 1996 Jul-Aug;81(4):302-9.

Supplemental Content

Loading ...
Support Center